# US 2026/0027261 A1 · Solid substrates for promoting cell and tissue growth

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0027261 A1
- Document ID: US20260027261A1
- Status: Published application
- Kind: A1
- Application number: 19/338,102
- Filed: 2025-09-24
- Published: 2026-01-29
- Earliest claimed: 2013-02-13
- Assignees: Cartiheal (2009) Ltd.
- Applicants: Cartiheal (2009) Ltd.
- Inventors: Nir Altschuler
- Web page: https://patentgrep.com/patent/US20260027261A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61F 2/28: Bones
- A61F 2/30: Joints
- A61F 2/30756: {Cartilage endoprostheses (A61F2/3603 takes precedence)}
- A61L 27/12: Phosphorus-containing materials, e.g. apatite
- A61L 27/20: Polysaccharides
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3637: {characterised by the origin of the biological material other than human or animal, e.g. plant extracts, algae}
- A61L 27/365: {Bones}
- A61L 27/3654: {Cartilage, e.g. meniscus}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/40: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/52: Hydrogels or hydrocolloids
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 15/00: Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives
- A61P 17/06: Antipsoriatics
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 27/02: Ophthalmic agents
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 33/00: Antiparasitic agents
- A61P 35/00: Antineoplastic agents
- A61P 37/02: Immunomodulators
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C01B 25/32: Phosphates of magnesium, calcium, strontium, or barium
- C01F 11/18: Carbonates
- G01N 1/00: Sampling; Preparing specimens for investigation
- A61F 2230/0006: circular
- A61F 2230/0065: toroidal, e.g. ring-shaped, doughnut-shaped
- A61F 2230/0067: conical
- A61F 2230/0069: cylindrical
- A61F 2230/0071: spherical
- A61F 2230/0086: Pyramidal, tetrahedral, or wedge-shaped
- A61L 2300/112: Phosphorus-containing compounds, e.g. phosphates, phosphonates
- A61L 2300/41: Anti-inflammatory agents, e.g. NSAIDs
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/414: Growth factors
- A61L 2300/426: Immunomodulating agents, i.e. cytokines, interleukins, interferons
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L 2430/06: for cartilage reconstruction, e.g. meniscus
- C01P 2006/90: Other properties not specified above
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C01B: NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; {METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C}
- C01F: COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS (metal hydrides {monoborane, diborane or addition complexes thereof} C01B6/00; salts of oxyacids of halogens C01B11/00; peroxides, salts of peroxyacids C01B15/00; sulfides or polysulfides of magnesium, calcium, strontium, or barium C01B17/42; thiosulfates, dithionites, polythionates C01B17/64; compounds containing selenium or tellurium C01B19/00; binary compounds of nitrogen with metals C01B21/06; azides C01B21/08; {compounds other than ammonia or cyanogen containing nitrogen and non-metals and optionally metals C01B21/082; amides or imides of silicon C01B21/087}; metal {imides or} amides C01B21/092, {C01B21/0923}; nitrites C01B21/50; {compounds of noble gases C01B23/0005}; phosphides C01B25/08; salts of oxyacids of phosphorus C01B25/16; carbides C01B32/90; compounds containing silicon C01B33/00; compounds containing boron C01B35/00; compounds having molecular sieve properties but not having base-exchange properties C01B37/00; compounds having molecular sieve and base-exchange properties, e.g. crystalline zeolites, C01B39/00; cyanides C01C3/08; salts of cyanic acid C01C3/14; salts of cyanamide C01C3/16; thiocyanates C01C3/20; {double sulfates of magnesium with sodium or potassium C01D5/12; with other alkali metals C01D15/00, C01D17/00})
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C01P: INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS

## Abstract

This invention provides solid substrates for promoting cell or tissue growth or restored function, which solid substrate is characterized by a specific fluid uptake capacity value of at least 75%, which specific fluid uptake capacity value is determined by establishing a spontaneous fluid uptake value divided by a total fluid uptake value. This invention also provides solid substrates for promoting cell or tissue growth or restored function, which solid substrate is characterized by having a contact angle value of less than 60 degrees, when in contact with a fluid. This invention also provides solid substrates for promoting cell or tissue growth or restored function, which said substrate is characterized by a substantial surface roughness (Ra) as measured by scanning electron microscopy or atomic force microscopy. The invention also provides for processes for selection of an optimized coral-based solid substrate for promoting cell or tissue growth or restored function and applications of the same.

## Claims

### Claim 1

An implantable solid substrate for promoting cartilage growth at an osteochondral defect, the solid substrate comprising:
a marine organism skeletal derivative-based solid material;
wherein the marine organism skeletal derivate-based solid material has a specific fluid uptake capacity value of at least 75%, or a contact angle value of less than 60 degrees when in contact with a fluid.

### Claim 2 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material exhibits positive Feigl staining indicating aragonite crystalline structure.

### Claim 3 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material is derived from a coral selected from Porites, Goniopora, Millepora, or Acropora species.

### Claim 4 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material has a specific fluid uptake capacity value of at least 75%.

### Claim 5 (depends on 4)

The solid substrate of claim 4, wherein the specific fluid uptake capacity value is determined by determining the marine organism skeletal derivative-based solid material's spontaneous fluid uptake value, determining the marine organism skeletal derivative-based solid material's total fluid uptake value, and dividing the spontaneous fluid uptake value by the total fluid uptake value.

### Claim 6 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material has a contact angle value of less than 60 degrees when in contact with a fluid.

### Claim 7 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material has both a specific fluid uptake capacity value of at least 75% and a contact angle value of less than 60 degrees when in contact with a fluid.

### Claim 8 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material has substantial surface roughness as measured by scanning electron microscopy or atomic force microscopy.

### Claim 9 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material promotes osteointegration, osteoconduction, and/or osteotransduction.

### Claim 10 (depends on 1)

The solid substrate of claim 1, wherein the marine organism skeletal derivative-based solid material contains a plurality of hollows extending into the marine organism skeletal derivative-based solid material from an end surface of the marine organism skeletal derivative-based solid material.

### Claim 11 (depends on 1)

The solid substrate of claim 1, further comprising a hydrogel applied to the marine organism skeletal derivative-based solid material.

### Claim 12 (depends on 11)

The solid substrate of claim 11, wherein the hydrogel is incorporated into voids or pores in the marine organism skeletal derivative-based solid material.

### Claim 13 (depends on 11)

The solid substrate of claim 11, wherein the hydrogel is attached to an outer surface of the marine organism skeletal derivative-based solid material.

### Claim 14

An apparatus for determining specific fluid uptake capacity values of marine organism skeletal derivative-based solid materials, comprising:
a holding cassette configured to hold a plurality of marine organism skeletal derivative-based solid materials;
a cassette manipulator configured to raise and lower the cassette into fluid;
a manipulator configured to individually orient the plurality of marine organism skeletal derivative-based solid materials for weight determination; and
a data processing unit configured to calculate specific fluid uptake capacity values of the plurality of marine organism skeletal derivative-based solid materials.

### Claim 15 (depends on 14)

The apparatus of claim 14, wherein the cassette manipulator is configured to position the plurality of marine organism skeletal derivative-based solid materials at different fluid levels for spontaneous and total fluid uptake measurements.

### Claim 16 (depends on 14)

The apparatus of claim 14, further comprising a drying station configured to remove excess fluid from the plurality of marine organism skeletal derivative-based solid materials between measurements.

### Claim 17 (depends on 14)

The apparatus of claim 14, wherein the data processing unit is configured to automatically identify one or more of the marine organism skeletal derivative-based solid materials meeting predetermined specific fluid uptake capacity criteria.

### Claim 18 (depends on 14)

The apparatus of claim 14, wherein the apparatus is automated.

### Claim 19 (depends on 14)

The apparatus of claim 14, wherein the apparatus outputs an indication of which marine organism skeletal derivative-based solid materials are to be selected based on indicated criteria.

### Claim 20 (depends on 19)

The apparatus of claim 19, wherein the indicated criteria comprise having a specific fluid uptake capacity value of at least 75%, or a contact angle value of less than 60 degrees when in contact with a fluid.
